Substance abuse and symptoms of mental illness among HIV-positive persons in the southeast

被引:38
作者
Whetten, K
Reif, SS
Napravnik, S
Swartz, MS
Thielman, NM
Eron, JJ
Lowe, K
Soto, T
机构
[1] Duke Univ, Dept Publ Policy, Durham, NC 27708 USA
[2] Duke Univ, Dept Commun & Family Med, Durham, NC 27708 USA
[3] Duke Univ, Hlth Inequalit Program, Durham, NC 27708 USA
[4] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27515 USA
[5] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Div Infect Dis & Internal Hlth, Durham, NC 27708 USA
[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA
[7] Cook Cty Hosp, CORE Ctr, Dept Res, Chicago, IL 60612 USA
关键词
AIDS; HIV; mental health; patient care; substance-related disorders;
D O I
10.1097/01.SMJ.0000149371.37294.66
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Mental illness and substance abuse have been consistently associated with poor HIV-medication adherence and other negative health outcomes. Methods: A brief mental health and substance use screening instrument was administered to 1,362 HIV-infected individuals receiving care at two academic medical center Infectious Diseases Clinics in North Carolina. Results: Study results indicated high frequencies of symptoms of mental illness (60%), substance abuse (32%), and co-occurring symptoms of mental illness and substance abuse (23%). Younger age (P = 0.03). male sex (P < 0.001), and higher viral load (P < 0.001) were associated with substance use problems. White race (P = 0.001), younger age (P = 0.023), and higher viral load (P 0.042) were associated with symptoms of mental illness. Conclusions: In the Southeast, mental health and substance abuse services are sparse and stigma is high; thus, innovative treatment strategies are needed to address the high levels of co-occurring mental illness and substance abuse. Antiretroviral therapies will not reach their potential for slowing the HIV/AIDS epidemic and prolonging survival if comorbidities that influence patient behavior are not addressed.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 58 条
  • [1] [Anonymous], 1979, Compliance in health care
  • [2] Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    Arnsten, JH
    Demas, PA
    Grant, RW
    Gourevitch, MN
    Farzodegan, H
    Howard, AA
    Schoenboum, EE
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) : 377 - 381
  • [3] Continuation of high-risk behavior by HIV-positive drug users - Treatment implications
    Avants, SK
    Warburton, LA
    Hawkins, KA
    Margolin, A
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2000, 19 (01) : 15 - 22
  • [4] Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
    Bangsberg, DR
    Hecht, FM
    Charlebois, ED
    Zolopa, AR
    Holodniy, M
    Sheiner, L
    Bamberger, JD
    Chesney, MA
    Moss, A
    [J]. AIDS, 2000, 14 (04) : 357 - 366
  • [5] Addressing the challenges of adherence
    Bartlett, JA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 : S2 - S10
  • [6] HIV AIDS in nonurban Alabama: Risk activities and access to services among HIV-infected persons
    Beltrami, JF
    Vermund, SH
    Fawal, HJ
    Moon, TD
    Von Bargen, JC
    Holmberg, SD
    [J]. SOUTHERN MEDICAL JOURNAL, 1999, 92 (07) : 677 - 683
  • [7] HIV-1 drug resistance in newly infected individuals
    Boden, D
    Hurley, A
    Zhang, LQ
    Cao, YZ
    Guo, Y
    Jones, E
    Tsay, J
    Ip, J
    Farthing, C
    Limoli, K
    Parkin, N
    Markowitz, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12): : 1135 - 1141
  • [8] THE ALCOHOL-USE DISORDERS IDENTIFICATION TEST (AUDIT) - VALIDATION OF A SCREENING INSTRUMENT FOR USE IN MEDICAL SETTINGS
    BOHN, MJ
    BABOR, TF
    KRANZLER, HR
    [J]. JOURNAL OF STUDIES ON ALCOHOL, 1995, 56 (04): : 423 - 432
  • [9] BOZZETTE S, 2003, COMMUNICATION 1215
  • [10] Resistance to antiretroviral drugs in patients with primary HIV-1 infection
    Brenner, B
    Wainberg, MA
    Salomon, H
    Rouleau, D
    Dascal, A
    Spira, B
    Sekaly, RP
    Conway, B
    Routy, JP
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (04) : 429 - 434